80 filings
Page 2 of 4
8-K
h7cocr
10 Nov 22
Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:14pm
8-K
4eyit94a
10 Aug 22
Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
4:07pm
8-K
87665
10 Jun 22
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
d6oztzv628mg jjg
12 May 22
Bolt Biotherapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights
4:07pm
DEFA14A
hj6my6101w2cstdwqb
28 Apr 22
Additional proxy soliciting materials
4:10pm
DEF 14A
acuizmrhm 10om
28 Apr 22
Definitive proxy
4:06pm
EFFECT
7zy67ur
8 Apr 22
Notice of effectiveness
12:15am
424B5
198 tstktsb
7 Apr 22
Prospectus supplement for primary offering
5:08pm
UPLOAD
044n4 jqx3tthfyawp
6 Apr 22
Letter from SEC
12:00am
CORRESP
f8khdd y4ioa
5 Apr 22
Correspondence with SEC
12:00am
S-3
ar9no
30 Mar 22
Shelf registration
5:14pm
S-8
jubktb74f63q9
30 Mar 22
Registration of securities for employees
4:48pm
8-K
qk90dx5 pv
30 Mar 22
Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business Highlights
4:03pm
8-K
xtvz1wj6ez7um4
4 Mar 22
Departure of Directors or Certain Officers
9:01am
8-K
u6y3u
25 Jan 22
Entry into a Material Definitive Agreement
4:05pm
8-K
9jf5es6a9dlv
16 Dec 21
Departure of Directors or Certain Officers
9:00am